Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- MEDICAL FACILITIES & NURSING CARE NEWS IN BREIF
March 24, 2003
- Advanced Technologies Contributing to Cardiac Diseases: ACCJ Seminar
March 24, 2003
- NEW PRODUCTS
March 24, 2003
- Sumitomo Gets Rights to Develop, Market Glucophage in Japan From Merck-Sante
March 24, 2003
- OTC NEWS IN BREIF
March 24, 2003
- Scottish Biotech Industry Lures Japanese Firms: Seminar
March 24, 2003
- Patent Strategy Important in Venture Businesses: Dr. Morishita of AnGes MG
March 24, 2003
- Cerebral Infarction Patients, Families Still Resisting Generics: LCA-J Survey
March 24, 2003
- GLs on Use of Biological Products to Treat RA Completed: Korosho Panel
March 24, 2003
- BUSINESS NEWS IN BRIEF
March 24, 2003
- Tsumura to Shift Development of Renal Failure Drug Overseas
March 24, 2003
- ON THE MOVE
March 24, 2003
- GEYMS to Launch 3T MR System
March 24, 2003
- Further Safety Measures Regarding Iressa to Be Recommended
March 24, 2003
- Iressa Shows 30% Response Rate in Many Hospitals
March 24, 2003
- Health Minister, JMA President Exchange Views on TV
March 24, 2003
- Taking Public Comments on Medical Device GCP Started
March 24, 2003
- Approval of Aventis Pharma's Arava, GSK's Imigran Recommended
March 17, 2003
- DIAGNOSTIC NEWS IN BRIEF
March 17, 2003
- REGULATORY NEWS IN BRIEF
March 17, 2003
ページ
Japan is ramping up its push to spread regional formularies nationwide, a policy expected to standardize treatments, strengthen supply resilience,…
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…